chartexchange

XPH
State Street SPDR S&P Pharmaceuticals ETF
stockNYSEETF

At CloseNov 18, 2026 3:59:50 PM EST
64.26USD+0.156%(+0.10)258,271
After-hoursNov 18, 2026 4:00:30 PM EST
64.23USD-0.047%(-0.03)
Loading…
Loading…
495.05M
HQ
MA, USA
Previous Close
$64.16
Beta
0.87
52-Week High
$74.35 2026-08-19
52-Week Low
$51.09 2025-11-20
SMA 50
$65.08
SMA 200
$62.34
Avg. Vol 10D
187,748
Avg. Vol 30D
193,404
Avg. Vol 90D
171,729
Relative Vol
1.34
7.70M
4.4300%
3,578
Dec 24, 2018 · $0.106
Sep 11, 2015 · 2-for-1
XPH Profile

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

XPH Performance
PeriodPriceDateChangeBeta
1W67.022026-11-12-4.07%1.403
1M62.242026-10-19+3.29%1.133
3M74.062026-08-19-13.19%1.014
6M55.812026-05-19+15.19%0.689
1Y52.172025-11-19+23.23%0.866
2Y45.242024-11-19+42.11%—
5Y48.132021-11-19+33.58%0.769
XPH Stock Summary

State Street SPDR S&P Pharmaceuticals ETF (NYSE:XPH) stock price today is $64.29, and today's volume is 258,271. XPH is up 0.203% today. The 30 day average volume is 193,404. XPH market cap is $495.05M with 7.70M shares outstanding.